Načítá se...

Case series of reports of pruritus and sipuleucel-T submitted to the Food and Drug Administration Adverse Event Reporting System

Sipuleucel-T, an autologous active cellular immunotherapy, is indicated for the treatment of asymptomatic or minimally symptomatic castration-resistant prostate cancer. The U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) received a report of pruritus without rash following t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Pharm Health Care Sci
Hlavní autoři: Dores, Graça M., Perez-Vilar, Silvia, Niu, Manette T.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6923907/
https://ncbi.nlm.nih.gov/pubmed/31890238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40780-019-0156-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!